Search
for
Sort by
Research 331–360 of 1000+
- Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth
- Isoxazole 9 (ISX9), a small molecule targeting Axin, activates Wnt/β‐catenin signalling and promotes hair regrowth
- Evaluation of the efficacy and safety of a dietary supplement on hair and skin aging in subjects with androgenic alopecia
- Nε-(carboxymethyl) lysine represses hair follicle formation by inhibiting Sonic hedgehog expression in a NF-κB-independent manner
- Single cell analysis of transcriptome and open chromatin reveals the dynamics of hair follicle stem cell aging
- Hair follicle–derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma
- <i>N</i>1-acetylspermidine is a determinant of hair follicle stem cell fate
- The anti‐apoptotic Bcl‐2 protein regulates hair follicle stem cell function
- A desmosomal cadherin controls multipotent hair follicle stem cell quiescence and orchestrates regeneration through adhesion signaling
- Hair Growth-Supporting and Follicle-Protective Potential of a Botanical-Based Supplement Ingredient: In Vitro, Ex Vivo, and Molecular Docking Studies
- Maternal Melatonin Contributes to Offspring Hair Follicle Development Through Transcriptional Regulation of the AP-1 Complex and MAPK Pathway
- TLR9 activation in large wound induces tissue repair and hair follicle regeneration via γδT cells
- The Efficacy of Ostrich Antibodies to Dihydrotestosterone and 5<i>α</i>-Reductase in the Restoration of Hair Growth
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Androgen Receptor Accelerates Premature Senescence of Human Dermal Papilla Cells in Association with DNA Damage
- Phytochemicals and Nano-Phytopharmaceuticals Use in Skin, Urogenital and Locomotor Disorders: Are We There?
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Transdermal viprostol in the treatment of male pattern baldness
- Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial
- Unveiling a Shared Precursor Condition for Acne Keloidalis Nuchae and Primary Cicatricial Alopecias
- Topical Minoxidil 2% Solution (‘Regaine’) for Male Pattern Baldness Among Filipinos
- The Roles of EDA2R in Ageing and Disease
- Flavonoids and saponins: What have we got or missed?
- Determining Safe Excision Limits in FUE: Factors That Affect, and a Simple Way to Maintain, Aesthetic Donor Density
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- Cyberspace Chat: Platelet Rich Plasma (PRP): Pseudoscience or Fact
- Alopecia areata – Current understanding and management
- Androgenetic alopecia – Current status
- Methodologic considerations in evaluating early clinical outcomes of GT20029 for androgenetic alopecia
- Enhanced therapeutic effects of all-trans retinoic acid nanostructured lipid carrier composite gel drug delivery system for alopecia areata